by EmpathiCSubstanceS | Apr 25, 2021 | Microdosing
A novel Australian trial is set to investigate the popular yet still deeply unproven practice of microdosing psychedelics. The research promises to be the first exploration of naturalistic psilocybin microdosing in a lab-setting using a cutting-edge neuroimaging...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana
New research from scientists at Stanford University School of Medicine suggests cannabis use can be linked to higher rates of “rebound headaches” in migraine sufferers. The research is observational and retrospective, but it is yet another...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana
Cannabidiol, better known as CBD, is rapidly gaining popularity as a potion to treat almost every kind of medical concern you can think of, but scientific evidence is scant outside of a few clinically proven indications. A new study from a team of Canadian researchers...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana
A broad drug reform bill has been introduced to the California state legislature proposing to decriminalize the possession and personal use of a number of psychedelic drugs, including LSD, psilocybin and MDMA. The bill proposes to expunge all criminal convictions...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Alcoholism
A new study published in the Journal of Psychopharmacology is reporting on a landmark clinical trial exploring the potential for MDMA-assisted psychotherapy in treating subjects with alcohol use disorder. The small open-label trial is the first to test MDMA therapy as...
